Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.

CONCLUSION: Fluoxetine seems to be a better cost-utility SSRI option for treating depressive disorders in PC.
PMID: 17087814 [PubMed - indexed for MEDLINE]

Source: Acta Psychiatrica Scandinavica Supplementum - March 9, 2013 Category: Psychiatry Tags: Acta Psychiatr Scand Suppl Source Type: research